Predicting a Survival Path in Hodgkin Lymphoma
Investigators from Rutgers Cancer Institute, along with Tufts Medical Center, developed and validated a state-of-the-art clinical decision model to predict five-year progression-free and overall survival in adults with advanced-stage classic Hodgkin lymphoma using comprehensive individual patient data from international clinical trials and large prospective cancer registries. Learn More
